Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Solange Peters

Showing results (341-350 of 362) with videos related to

Pageof 37
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 23, 2020
A Randomized Open-Label Phase III Trial Evaluating the Addition of Denosumab to Standard First-Line Treatment in Advanced NSCLC: The European Thoracic Oncology Platform (ETOP) and European Organisation for Research and Treatment of Cancer (EORTC) SPLENDOUR TrialSolange Peters, Sarah Danson, Baktiar Hasan, et al.
Journal for Immunotherapy of Cancer|November 30, 2022
Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: a joint analysis of OnCovid and ESMO-CoCARE registriesAlessio Cortellini, Gino M Dettorre, Urania Dafni, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 10, 2026
Advances in the Basic Sciences in Thoracic Oncology in the Last 20 Years and Their Translational ImpactMichele Carbone, Christopher Amos, Richard L Attanoos, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 13, 2026
Corrigendum to 'Advances in the Basic Sciences in Thoracic Oncology in the Last 20 Years and Their Translational Impact' [Journal of Thoracic Oncology Volume 21 Issue 1 (2026) 41-76]Michele Carbone, Christopher Amos, Richard L Attanoos, et al.
ESMO Open|March 4, 2017
Career opportunities and benefits for young oncologists in the European Society for Medical Oncology (ESMO)Gilberto Morgan, Matteo Lambertini, Hampig Raphael Kourie, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 10, 2019
Definition of Synchronous Oligometastatic Non-Small Cell Lung Cancer-A Consensus ReportAnne-Marie C Dingemans, Lizza E L Hendriks, Thierry Berghmans, et al.
The Lancet. Oncology|June 17, 2026
Development and validation of artificial intelligence-assisted volumetric response criteria in pleural mesothelioma (ARTIMES): a retrospective, multicohort, multicentre studyKevin B W Groot Lipman, Rianne Wittenberg, Mateus de Oliveira Taveira, et al.
Journal of Thrombosis and Haemostasis : JTH|July 14, 2021
The CoVID-TE risk assessment model for venous thromboembolism in hospitalized patients with cancer and COVID-19Ang Li, Nicole M Kuderer, Chih-Yuan Hsu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 12, 2020
The Promises and Challenges of Tumor Mutation Burden as an Immunotherapy Biomarker: A Perspective from the International Association for the Study of Lung Cancer Pathology CommitteeLynette M Sholl, Fred R Hirsch, David Hwang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 26, 2016
Scientific Advances in Lung Cancer 2015Anne S Tsao, Giorgio V Scagliotti, Paul A Bunn, et al.
Pageof 37

Showing results (341-350 of 362) with videos related to

Sort By:
Pageof 37
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 23, 2020
A Randomized Open-Label Phase III Trial Evaluating the Addition of Denosumab to Standard First-Line Treatment in Advanced NSCLC: The European Thoracic Oncology Platform (ETOP) and European Organisation for Research and Treatment of Cancer (EORTC) SPLENDOUR TrialSolange Peters, Sarah Danson, Baktiar Hasan, et al.
Journal for Immunotherapy of Cancer|November 30, 2022
Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: a joint analysis of OnCovid and ESMO-CoCARE registriesAlessio Cortellini, Gino M Dettorre, Urania Dafni, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 10, 2026
Advances in the Basic Sciences in Thoracic Oncology in the Last 20 Years and Their Translational ImpactMichele Carbone, Christopher Amos, Richard L Attanoos, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 13, 2026
Corrigendum to 'Advances in the Basic Sciences in Thoracic Oncology in the Last 20 Years and Their Translational Impact' [Journal of Thoracic Oncology Volume 21 Issue 1 (2026) 41-76]Michele Carbone, Christopher Amos, Richard L Attanoos, et al.
ESMO Open|March 4, 2017
Career opportunities and benefits for young oncologists in the European Society for Medical Oncology (ESMO)Gilberto Morgan, Matteo Lambertini, Hampig Raphael Kourie, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 10, 2019
Definition of Synchronous Oligometastatic Non-Small Cell Lung Cancer-A Consensus ReportAnne-Marie C Dingemans, Lizza E L Hendriks, Thierry Berghmans, et al.
The Lancet. Oncology|June 17, 2026
Development and validation of artificial intelligence-assisted volumetric response criteria in pleural mesothelioma (ARTIMES): a retrospective, multicohort, multicentre studyKevin B W Groot Lipman, Rianne Wittenberg, Mateus de Oliveira Taveira, et al.
Journal of Thrombosis and Haemostasis : JTH|July 14, 2021
The CoVID-TE risk assessment model for venous thromboembolism in hospitalized patients with cancer and COVID-19Ang Li, Nicole M Kuderer, Chih-Yuan Hsu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 12, 2020
The Promises and Challenges of Tumor Mutation Burden as an Immunotherapy Biomarker: A Perspective from the International Association for the Study of Lung Cancer Pathology CommitteeLynette M Sholl, Fred R Hirsch, David Hwang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 26, 2016
Scientific Advances in Lung Cancer 2015Anne S Tsao, Giorgio V Scagliotti, Paul A Bunn, et al.
Pageof 37